BAIT
TOP1
TOPI, RP3-511B24.1
topoisomerase (DNA) I
GO Process (9)
GO Function (6)
GO Component (6)
Gene Ontology Biological Process
Gene Ontology Molecular Function
Gene Ontology Cellular Component
Homo sapiens
PREY
CDC6
CDC18L, HsCDC18, HsCDC6
cell division cycle 6
GO Process (12)
GO Function (3)
GO Component (7)
Gene Ontology Biological Process
- DNA replication [TAS]
- DNA replication checkpoint [TAS]
- G1/S transition of mitotic cell cycle [TAS]
- mitotic cell cycle [TAS]
- negative regulation of DNA replication [TAS]
- negative regulation of cell proliferation [TAS]
- positive regulation of chromosome segregation [IDA]
- positive regulation of cytokinesis [IMP]
- regulation of cyclin-dependent protein serine/threonine kinase activity [TAS]
- regulation of mitotic metaphase/anaphase transition [IMP]
- regulation of transcription involved in G1/S transition of mitotic cell cycle [TAS]
- traversing start control point of mitotic cell cycle [TAS]
Gene Ontology Molecular Function
Gene Ontology Cellular Component
Homo sapiens
Synthetic Lethality
A genetic interaction is inferred when mutations or deletions in separate genes, each of which alone causes a minimal phenotype, result in lethality when combined in the same cell under a given condition.
Publication
A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.
An emerging therapeutic strategy for cancer is to induce selective lethality in a tumor by exploiting interactions between its driving mutations and specific drug targets. Here we use a multi-species approach to develop a resource of synthetic lethal interactions relevant to cancer therapy. First, we screen in yeast ∼169,000 potential interactions among orthologs of human tumor suppressor genes (TSG) and ... [more]
Mol. Cell Aug. 04, 2016; 63(3);514-25 [Pubmed: 27453043]
Throughput
- High Throughput
Ontology Terms
- phenotype: growth abnormality (HP:0001507) [hela cell (BTO:0000567)]
Additional Notes
- Chemo-genetic screen with siRNAs
- Drug target: TOP1,TOP2A,TOP3A triple mutant
- Drug: irinotecan
- HeLa cervical cancer cell line
Curated By
- BioGRID